894: Can we predict yield of Chromosomal Microarray in intrauterine growth restriction according to clinical parameters? - 25/12/18
Doi : 10.1016/j.ajog.2018.11.918
Keren Tzadikevitch Geffen 1, 2, Amihood Singer 3, Idit Maya 4, Shay Ben-Shachar 5, Lena Sagi-Dain 6, Rivka Sukenik Halevy 7, 8
1 Department of OBGYN, Meir Medical Center, Kfar Saba, Kfar Saba, Israel
2 Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel
3 Community Genetics, Public Health Services, Ministry of Health, Jerusalem, Jerusalem, Israel
4 Recanati Genetics Institute, Rabin Medical Center, Petah Tikva, Petah Tikva, Israel
5 The Genetic Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Tel Aviv, Israel
6 Genetics Institute and Department of OB-GYN, Carmel Medical Center, Haifa, Haifa, Israel
7 Recanati Genetics Institute, Rabin Medical Center, Petah Tikva, Petah Tikva, Israel
8 Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Tel Aviv, Israel
Le texte complet de cet article est disponible en PDF.
Plan
© 2018
Publié par Elsevier Masson SAS.
Vol 220 - N° 1S
P. S579-S580 - janvier 2019 Retour au numéro
Article précédent
- 893: Clinical utility of expanded carrier screening: Results-guided actionability and outcomes
- Katie Johansen Taber, Kyle Beauchamp, Gabriel Lazarin, Dale Muzzey, Aishwarya Arjunan, Jim Goldberg
- 895: Impact of twenty-week abortion bans in the setting of advances in prenatal diagnoses: cost-effectiveness analysis
- Kimberley A. Bullard, Rachel A. Pilliod, Brian L. Shaffer, Maria I. Rodriguez, Aaron B. Caughey
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?